Leidos director Dahlberg sells $168,911 in shares

Published 13/08/2025, 23:10
Leidos director Dahlberg sells $168,911 in shares

Leidos Holdings, Inc. NASDAQ:LDOS Director Gregory R. Dahlberg sold 952 shares of common stock on August 11, 2025, at a weighted average price of $177.4276, for a total value of $168,911. The sales occurred in multiple transactions with prices ranging from $177.40 to $177.45. The stock has since climbed to $181.94, with the $23.34B market cap company maintaining a "GREAT" financial health score according to InvestingPro analysis.

On the same day, Dahlberg also exercised options to acquire a total of 2948 shares of Leidos common stock. These transactions involved two separate option exercises. The first involved 1,769 shares at an exercise price of $104.06, and the second involved 1,179 shares at an exercise price of $142.66. The total value for "M" transactions was $352278.

Additionally, 1,996 shares were withheld by Leidos to cover the exercise price and associated fees related to the option exercises, resulting in a total value of $352294 at a price of $176.50.

Following these transactions, Dahlberg directly owns 21,068 shares of Leidos Holdings , Inc.

In other recent news, Leidos Holdings Inc. reported strong financial results for the second quarter of 2025, with earnings per share (EPS) of $3.21, surpassing forecasts of $2.64 by 21.59%. Revenue was slightly above expectations, coming in at $4.25 billion compared to the anticipated $4.24 billion. Following these results, Leidos raised its fiscal year 2025 guidance. Stifel responded by raising its price target for Leidos to $204 from $178, maintaining a Buy rating, while UBS increased its target to $184 from $168, citing strong margins. Additionally, Leidos secured a $105.5 million contract from the U.S. Department of Defense for operational readiness research support services at the Naval Health Research Center. In another development, Leidos announced a strategic partnership with Second Front Systems to expedite software delivery across federal agencies. These recent developments reflect Leidos’ ongoing efforts to enhance its operational capabilities and financial performance.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.